|
| |
| | | 56239 | | 21.04.2005 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.15. | | | | 07.15. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Certican 0.25 mg | dispergierbare Tabletten | Dispersible Tabletten (Everolimus 0.25 mg) | L04AA18 | PI | | 02 | Certican 0.1 mg | dispergierbare Tabletten | Dispersible Tabletten (Everolimus 0.1 mg) | L04AA18 | PI |
|
|
|
